The agreement with Fundação Biominas and GlaxoSmithKline Brasil (GSK) aims to develop a programme whereby selected research institutions from the State of São Paulo will receive funding and in-kind support to conduct scientific research activities in the areas of respiratory, immuno-inflammation, immuno-oncology, and human immunodeficiency virus (HIV).